Summary
The control mechanisms for the transgene expression in mice that carry the hepatitis B virus genome defective in the polymerase and X genes were analyzed. Ten lines of transgenic mouse were established, and in seven lines the surface and e antigens were detected in the serum. In transgenic mice from five lines examined, the transgene was markedly expressed in a broad spectrum of tissues including the kidney, heart, brain, muscle and intestine, but only poorly in the liver. In the kidney and heart the 3.5 kb and 2.1 kb mRNAs were expressed, whereas only the 0.8 kb and 4.0 kb mRNAs were detected in the testis and brain, respectively, suggesting that each of the mRNAs was transcribed through a different control mechanism. The surface, e and core antigens accumulated in the kidney and heart. DNA was hypomethylated at a region closely downstream of the enhancer in the liver, kidney and heart, and a DNase I hypersensitive site was detected upstream of the enhancer in these tissues. In the testis, however, the whole transgene was hypomethylated and the DNase I hypersensitive site was closer to the enhancer. These differences may be relevant to the preferential expression of the 0.8 kb mRNA in the testis, but cannot explain the inefficiency of transgene expression in the liver. Our observations suggest that the X protein is required for efficient expression of the viral gene in the liver but not in other tissues.
Similar content being viewed by others
References
Akmal M, El-Ghor A, Burk RD (1989) DNase I hypersensitive site maps to the HBV enhancer. Virology 172: 478–488
Araki K, Miyazaki J, Hino O, Tomita N, Chisaka O, Matsubara K, Yamamura K (1989) Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA 86: 207–211
Araki K, Miyazaki J, Tsurimoto T, Inomoto T, Iwanaga T, Matsubara K, Yamamura K (1989) Demethylation by 5-azacytidine results in the expression of hepatitis B virus surface antigen in transgenic mice. Jpn J Cancer Res 80: 295–298
Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C (1985) Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230: 1160–1163
Becker P, Renkawitz R, Schutz G (1984) Tissue specific DNase I hypersensitive sites in the 5′-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes. EMBO J 3: 2015–2020
Blum HE, Gerok W, Vyas GN (1989) The molecular biology of hepatitis B virus. Trends Genet 5: 154–158
Blum HE, Stowring L, Figus A, Montgomery CK, Haase AT, Vyas GN (1983) Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci USA 80: 6685–6688
Burk RD, Deloia JA, Elawady MK, Gearhart JD (1988) Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J Virol 62: 649–654
Cedar H (1988) DNA methylation and gene activity. Cell 53: 3–4
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299
Chisari FV, Pinkert CA, Milich DR, Fillipi P, McLachlan A, Palmiter RD, Brinster RL (1985) A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230: 1157–1160
Choo K-B, Liew L-N, Chong KY, Lu R, Cheng WTK (1991) Transgenome transcription and replication in the liver and extrahepatic tissues of a human hepatitis B virus transgenic mouse. Virology 182: 785–792
Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C (1984) Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 65: 651–655
Elgin SCR (1988) The formation and function of DNase I hypersensitive sites in the process of gene activation. J Biol Chem 263: 19259–19262
Faktor O, Shaul Y (1990) The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. Oncogene 5: 867–872
Farza H, Hadechouel M, Scotto J, Tiollais P, Babinet C, Pourcel C (1988) Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol 62: 4144–4152
Fritton HP, Sippel AE, Igo-Kemenes T (1983) Nuclear-hypersensitive sites in the chromatin domain of the chicken lysozyme gene. Nucleic Acids Res 11: 3467–3485
Gocke DJ (1975) Extrahepatic manifestations of viral hepatitis. Am J Med Sci 270: 49–52
Guo W, Wang J, Tam G, Yen TSB, Ou J (1991) Leaky tanscription termination produces larger and smaller than genome size hepatitis B virus X gene transcripts. Virology 181: 630–636
Hadchouel M, Farza H, Simon D, Tiollais P, Pourcel C (1987) Maternal inhibition of hepatitis B surface antigen gene expression in transgenic mice correlates with de novo methylation. Nature 329: 454–456
Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9: 1137–1145
Hu K-Q, Siddiqui A (1991) Regulation of the hepatitis B virus gene expression by the enhancer element I. Virology 181: 721–726
Iwakura Y, Asano M, Nishimune Y, Kawada Y (1988) Male sterility of transgenic mice carrying exogenous mouse interferon-β gene under the control of the metallothionein enhancer-promoter. EMBO J 7: 3757–3762
Kim C-M, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317–320
Koike K, Shirakata Y, Yaginuma K, Arii M, Takada S, Nakamura I, Hayashi Y, Kawada M, Kobayashi M (1989) Oncogenic potential of hepatitis B virus. Mol Biol Med 6: 151–160
Lai KN, Lai FM-M, Lo S, Leung A (1987) Is there a pathogenetic role of hepatitis B in lupus nephritis? Arch Pathol Lab Med 111: 185–188
Landschulz WH, Johnson PF, Adashi EY, Graves BJ, McKnight SL (1988) Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 2: 786–800
Laure F, Zagury D, Saimot AG, Gallo RC, Hahn BH, Brechot C (1985) Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Science 229: 561–563
Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP 6 promoter. Nucleic Acids Res 12: 7035–7056
Miller RH, Robinson W (1983) Integrated hepatitis B virus DNA sequences specifying the major viral core polypeptide are methylated in PLC/PRF/5 cells. Proc Natl Acad Sci USA 80: 2534–2538
Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizaka H, Gotanda T, Tsuda F, Miyakawa Y, Mayumi M (1986) Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol 67: 2305–2314
Poli V, Mancini FP, Cortese R (1990) IL-6 DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63: 643–653
Pontisso P, Locasciulli A, Schiavon E, Cattoretti G, Schiro R, Stenico D, Alberti A (1987) Detection of hepatitis B virus DNA sequences in bone marrow of children with leukemia. Cancer 59: 292–296
Pourcel C, Tiollais P, Farza H (1990) Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity. J Virol 64: 931–935
Roman C, Platero JS, Shuman J, Calame K (1990) Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev 4: 1404–1415
Schumacher HR, Gall EP (1974) Arthritis in acute hepatitis and chronic active hepatitis. Pathology of the synovial membrane with evidence for the presence of Australia antigen in synovial membranes. Am J Med 57: 655–664
Seto E, Yen TSB, Peterlin BM, Ou JH (1988) Transactivation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85: 8286–8290
Siddqui A (1983) Hepatitis B virus DNA in Kaposi sarcoma. Proc Natl Acad Sci USA 80: 4861–4864
Somlo F (1989) Localization of hepatitis B virus in a primary testicular cancer. Arch Pathol Lab Med 113: 1184–1186
Spandau DF, Lee CH (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 62: 427–434
Takada S, Koike K (1990) Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87: 5628–5632
Thomas PS (1980) Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77: 5201–5205
Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature 317: 489–495
Twu JS, Schloemer RH (1987) Transcriptionaltrans-activating function of hepatitis B virus. J Virol 61: 3448–3453
Vannice JL, Levinson AD (1988) Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol 62: 1305–1313
Weiss TD, Tsai CC, Baldassare AR, Zuckner J (1978) Skin lesions in viral hepatitis. Am J Med 64: 269–273
Wollershein M, Debelka U, Hofschneider PH (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3: 545–552
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagashima, H., Imai, M. & Iwakura, Y. Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene. Archives of Virology 132, 381–397 (1993). https://doi.org/10.1007/BF01309547
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309547